BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26599546)

  • 21. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.
    Guiter C; Dusanter-Fourt I; Copie-Bergman C; Boulland ML; Le Gouvello S; Gaulard P; Leroy K; Castellano F
    Blood; 2004 Jul; 104(2):543-9. PubMed ID: 15044251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.
    Xie L; Ritz O; Leithäuser F; Guan H; Färbinger J; Weitzer CD; Gehringer F; Bruederlein S; Holzmann K; Vogel MJ; Möller P; Wirth T; Ushmorov A
    Oncotarget; 2014 Jul; 5(14):5392-402. PubMed ID: 24977668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.
    Tanaka Y; Maeshima AM; Nomoto J; Makita S; Fukuhara S; Munakata W; Maruyama D; Tobinai K; Kobayashi Y
    Eur J Haematol; 2018 May; 100(5):511-517. PubMed ID: 29377256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.
    Steidl C; Shah SP; Woolcock BW; Rui L; Kawahara M; Farinha P; Johnson NA; Zhao Y; Telenius A; Neriah SB; McPherson A; Meissner B; Okoye UC; Diepstra A; van den Berg A; Sun M; Leung G; Jones SJ; Connors JM; Huntsman DG; Savage KJ; Rimsza LM; Horsman DE; Staudt LM; Steidl U; Marra MA; Gascoyne RD
    Nature; 2011 Mar; 471(7338):377-81. PubMed ID: 21368758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line.
    Melzner I; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Barth TF; Leithäuser F; Möller P
    Blood; 2005 Mar; 105(6):2535-42. PubMed ID: 15572583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.
    Ritz O; Leithäuser F; Hasel C; Brüderlein S; Ushmorov A; Möller P; Wirth T
    J Pathol; 2005 Feb; 205(3):336-48. PubMed ID: 15682441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.
    Scholtysik R; Kreuz M; Hummel M; Rosolowski M; Szczepanowski M; Klapper W; Loeffler M; Trümper L; Siebert R; Küppers R;
    Int J Cancer; 2015 Mar; 136(5):1033-42. PubMed ID: 25042405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonrandom chromosomal imbalances in primary mediastinal B-cell lymphoma detected by arbitrarily primed PCR fingerprinting.
    Scarpa A; Taruscio D; Scardoni M; Iosi F; Paradisi S; Ennas MG; Rigaud G; Moore PS; Menestrina F
    Genes Chromosomes Cancer; 1999 Nov; 26(3):203-9. PubMed ID: 10502317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity.
    Tuveri S; Debackere K; Marcelis L; Dierckxsens N; Demeulemeester J; Dimitriadou E; Dierickx D; Lefesvre P; Deraedt K; Graux C; Michaux L; Cools J; Tousseyn T; Vermeesch JR; Wlodarska I
    Genes Chromosomes Cancer; 2022 Oct; 61(10):603-615. PubMed ID: 35611992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
    Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
    Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
    Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
    J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathobiology of primary mediastinal B-cell lymphoma.
    Pileri SA; Zinzani PL; Gaidano G; Falini B; Gaulard P; Zucca E; Sabattini E; Ascani S; Rossi M; Cavalli F;
    Leuk Lymphoma; 2003; 44 Suppl 3():S21-6. PubMed ID: 15202521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets.
    Raia V; Schilling M; Böhm M; Hahn B; Kowarsch A; Raue A; Sticht C; Bohl S; Saile M; Möller P; Gretz N; Timmer J; Theis F; Lehmann WD; Lichter P; Klingmüller U
    Cancer Res; 2011 Feb; 71(3):693-704. PubMed ID: 21127196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade.
    Chapuy B; Stewart C; Dunford AJ; Kim J; Wienand K; Kamburov A; Griffin GK; Chen PH; Lako A; Redd RA; Cote CM; Ducar MD; Thorner AR; Rodig SJ; Getz G; Shipp MA
    Blood; 2019 Dec; 134(26):2369-2382. PubMed ID: 31697821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma.
    Copie-Bergman C; Boulland ML; Dehoulle C; Möller P; Farcet JP; Dyer MJ; Haioun C; Roméo PH; Gaulard P; Leroy K
    Blood; 2003 Apr; 101(7):2756-61. PubMed ID: 12446450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
    Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
    J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma.
    Dijkman R; Tensen CP; Jordanova ES; Knijnenburg J; Hoefnagel JJ; Mulder AA; Rosenberg C; Raap AK; Willemze R; Szuhai K; Vermeer MH
    J Clin Oncol; 2006 Jan; 24(2):296-305. PubMed ID: 16330669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.